Skip to main content
Top
Published in: Pituitary 1/2012

01-03-2012

Cushing’s syndrome: diagnosis and surveillance using salivary cortisol

Author: Hershel Raff

Published in: Pituitary | Issue 1/2012

Login to get access

Abstract

This short review summarizes the use of late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome, in the evaluation of patients with adrenal incidentalomas, and in monitoring of post-operative patients, with a focus on the different assay methodologies currently in common use. The focus is on recent studies identified by literature searches using Ovid Medline and Google Scholar as well as analysis of several recent review articles on the topic. Measurement of late night salivary cortisol (LNSC) has an excellent sensitivity and specificity for the diagnosis of Cushing’s syndrome regardless of the assay methodology used. Immunoassays have the advantage of simplicity, low cost, and small sample volume requirement, while liquid chromatography-tandem mass spectrometry has the advantage of a high specificity for cortisol and the ability to measure cortisone. The overnight dexamethasone suppression test appears to be superior to LNSC measurement in the evaluation of patients with adrenal incidentalomas. LNSC measurement is an excellent approach to monitor post-operative Cushing’s disease patients for surgical failure or recurrence. Salivary cortisol is most useful as the initial test when Cushing’s syndrome is suspected and for periodic patient monitoring after pituitary surgery for Cushing’s disease.
Literature
1.
go back to reference Raff H, Findling JW (2003) A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 138:980–991PubMed Raff H, Findling JW (2003) A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 138:980–991PubMed
2.
go back to reference Carroll T, Raff H, Findling JW (2008) Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome. Nat Clin Pract Endocrinol Metab 4:344–350PubMedCrossRef Carroll T, Raff H, Findling JW (2008) Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome. Nat Clin Pract Endocrinol Metab 4:344–350PubMedCrossRef
3.
go back to reference Findling JW, Raff H (2006) Cushing’s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3753PubMedCrossRef Findling JW, Raff H (2006) Cushing’s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3753PubMedCrossRef
4.
go back to reference Findling JW, Raff H (2001) Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 30:729–747PubMedCrossRef Findling JW, Raff H (2001) Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 30:729–747PubMedCrossRef
5.
go back to reference Findling JW, Raff H (1999) Newer diagnostic techniques and problems in Cushing’s disease. Endocrinol Metab Clin North Am 28:191–210PubMedCrossRef Findling JW, Raff H (1999) Newer diagnostic techniques and problems in Cushing’s disease. Endocrinol Metab Clin North Am 28:191–210PubMedCrossRef
6.
go back to reference Findling JW, Raff H (2005) Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 34:385–402PubMedCrossRef Findling JW, Raff H (2005) Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 34:385–402PubMedCrossRef
7.
go back to reference Raff H (2009) Utility of salivary cortisol measurement in Cushing’s syndrome and adrenal insufficiency. J Clin Endocrinol Metab 94:3647–3655PubMedCrossRef Raff H (2009) Utility of salivary cortisol measurement in Cushing’s syndrome and adrenal insufficiency. J Clin Endocrinol Metab 94:3647–3655PubMedCrossRef
8.
go back to reference Raff H (2004) Role of salivary cortisol determinations in the diagnosis of Cushing syndrome. Curr Opin Endocrinol Diab 11:271–275CrossRef Raff H (2004) Role of salivary cortisol determinations in the diagnosis of Cushing syndrome. Curr Opin Endocrinol Diab 11:271–275CrossRef
9.
go back to reference Carroll TB, Findling JW (2010) The diagnosis of Cushing’s syndrome. Rev Endocr Metab Disord 11:147–153PubMedCrossRef Carroll TB, Findling JW (2010) The diagnosis of Cushing’s syndrome. Rev Endocr Metab Disord 11:147–153PubMedCrossRef
10.
go back to reference Alexandraki KI, Grossman AB (2010) Novel insights in the diagnosis of Cushing’s syndrome. Neuroendocrinology 92:35–43PubMedCrossRef Alexandraki KI, Grossman AB (2010) Novel insights in the diagnosis of Cushing’s syndrome. Neuroendocrinology 92:35–43PubMedCrossRef
11.
go back to reference Yao KJ, Moss HB, Kirillova GP (1998) Determination of salivary cortisol by nonisotopic immunoassay. Clin Biochem 31:187–190PubMedCrossRef Yao KJ, Moss HB, Kirillova GP (1998) Determination of salivary cortisol by nonisotopic immunoassay. Clin Biochem 31:187–190PubMedCrossRef
12.
go back to reference Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, De Palo EF (2009) Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 42:1205–1217PubMedCrossRef Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, De Palo EF (2009) Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 42:1205–1217PubMedCrossRef
13.
go back to reference Carrozza C, Corsello SM, Paragliola RM, Ingraudo F, Palumbo S, Locantore P, Sferrazza A, Pontecorvi A, Zuppi C (2010) Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann Clin Biochem 47:228–232PubMedCrossRef Carrozza C, Corsello SM, Paragliola RM, Ingraudo F, Palumbo S, Locantore P, Sferrazza A, Pontecorvi A, Zuppi C (2010) Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann Clin Biochem 47:228–232PubMedCrossRef
14.
go back to reference Beko G, Varba I, Glaz E, Sereg M, Feldman K, Toth M, Racz K, Patocs A (2010) Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta 411:364–367PubMedCrossRef Beko G, Varba I, Glaz E, Sereg M, Feldman K, Toth M, Racz K, Patocs A (2010) Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta 411:364–367PubMedCrossRef
15.
go back to reference Yaneva M, Kirilov G, Zacharieva S (2009) Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing’s syndrome. Central Eur J Med 4:59–64CrossRef Yaneva M, Kirilov G, Zacharieva S (2009) Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing’s syndrome. Central Eur J Med 4:59–64CrossRef
16.
go back to reference Chiu SK, Collier CP, Clark AF, Wynn-Edwards KE (2003) Salivary cortisol on ROCHE Elecsys immunoassay system: pilot biological variation studies. Clin Biochem 36:211–214PubMedCrossRef Chiu SK, Collier CP, Clark AF, Wynn-Edwards KE (2003) Salivary cortisol on ROCHE Elecsys immunoassay system: pilot biological variation studies. Clin Biochem 36:211–214PubMedCrossRef
17.
go back to reference Hansen AM, Garde AH, Christensen JM, Eller NH, Netterstrøm B (2003) Evaluation of a radioimmunoassay and establishment of a reference interval for salivary cortisol in healthy subjects in Denmark. Scand J Clin Lab Invest 63:303–310PubMedCrossRef Hansen AM, Garde AH, Christensen JM, Eller NH, Netterstrøm B (2003) Evaluation of a radioimmunoassay and establishment of a reference interval for salivary cortisol in healthy subjects in Denmark. Scand J Clin Lab Invest 63:303–310PubMedCrossRef
18.
go back to reference Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK (2007) Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102–3107PubMedCrossRef Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK (2007) Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102–3107PubMedCrossRef
19.
go back to reference Vogeser M, Durner J, Seliger E, Auernhammer C (2006) Measurement of late-night salivary cortisol with an automated immunoassay system. Clin Chem Lab Med 44:1441–1445PubMedCrossRef Vogeser M, Durner J, Seliger E, Auernhammer C (2006) Measurement of late-night salivary cortisol with an automated immunoassay system. Clin Chem Lab Med 44:1441–1445PubMedCrossRef
20.
go back to reference Sakihara S, Kageyhama K, Oki Y, Doi M, Iwasaki Y, Takayasu S, Moriyama T, Terui K, Nibawara T, Hirata Y, Hashimoto K, Suda T (2010) Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr J 57:331–337PubMedCrossRef Sakihara S, Kageyhama K, Oki Y, Doi M, Iwasaki Y, Takayasu S, Moriyama T, Terui K, Nibawara T, Hirata Y, Hashimoto K, Suda T (2010) Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr J 57:331–337PubMedCrossRef
21.
go back to reference Perogamvros I, Owen LJ, Newell-Price J, Ray DW, Trainer PJ, Keevil B (2009) Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions. J Chromatogr B 877:3771–3775CrossRef Perogamvros I, Owen LJ, Newell-Price J, Ray DW, Trainer PJ, Keevil B (2009) Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions. J Chromatogr B 877:3771–3775CrossRef
22.
go back to reference Lee S, Kwon S, Shin HJ, Lim HS, Singh RJ, Lee KR, Kim YJ (2010) Simultaneous quantitative analysis of salivary cortisol and cortisone in Korean adults using LC-MS/MS. BMB Reports 43:506–511PubMedCrossRef Lee S, Kwon S, Shin HJ, Lim HS, Singh RJ, Lee KR, Kim YJ (2010) Simultaneous quantitative analysis of salivary cortisol and cortisone in Korean adults using LC-MS/MS. BMB Reports 43:506–511PubMedCrossRef
23.
go back to reference Jonsson BAG, Malmberg B, Amilon A, Garde AH, Orbaek P (2003) Determination of cortisol in human saliva using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B 784:63–68CrossRef Jonsson BAG, Malmberg B, Amilon A, Garde AH, Orbaek P (2003) Determination of cortisol in human saliva using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B 784:63–68CrossRef
24.
go back to reference Turpeinen U, Valimaki MJ, Hamalainen E (2009) Determination of salivary cortisol by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest 69:592–597PubMedCrossRef Turpeinen U, Valimaki MJ, Hamalainen E (2009) Determination of salivary cortisol by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest 69:592–597PubMedCrossRef
25.
go back to reference Owen LJ, Haslam S, Adaway JE, Wood P, Glenn C, Keevil BG (2010) A simplified liquid chromatography tandem mass spectrometry assay, using on-line solid-phase extraction, for the quantitation of cortisol in saliva and comparison with a routine DELFIA method. Ann Clin Biochem 47:131–136PubMedCrossRef Owen LJ, Haslam S, Adaway JE, Wood P, Glenn C, Keevil BG (2010) A simplified liquid chromatography tandem mass spectrometry assay, using on-line solid-phase extraction, for the quantitation of cortisol in saliva and comparison with a routine DELFIA method. Ann Clin Biochem 47:131–136PubMedCrossRef
26.
go back to reference Nelson EA, Palombo EA, Knowles SR (2008) Comparison of evaporation techniques for the preparation of salivary cortisol for analysis by liquid chromatography-electrospray tandem mass spectrometry. Clin Biochem 41:1413–1416PubMedCrossRef Nelson EA, Palombo EA, Knowles SR (2008) Comparison of evaporation techniques for the preparation of salivary cortisol for analysis by liquid chromatography-electrospray tandem mass spectrometry. Clin Biochem 41:1413–1416PubMedCrossRef
27.
go back to reference Kataoka H, Matsuura E, Mitani K (2007) Determination of cortisol in human saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J Pharmaceut Biomed Anal 44:160–165CrossRef Kataoka H, Matsuura E, Mitani K (2007) Determination of cortisol in human saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J Pharmaceut Biomed Anal 44:160–165CrossRef
28.
go back to reference Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, Kennedy L, Hatipoglu B, Weil RJ, Hamrahian AH (2010) Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 95:4555–4559PubMedCrossRef Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, Kennedy L, Hatipoglu B, Weil RJ, Hamrahian AH (2010) Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 95:4555–4559PubMedCrossRef
29.
go back to reference DePalo EF, Antonelli G, Benetazzo A, Prearo M, Gatti R (2009) Human saliva cortisone and cortisol simultaneous analysis using reverse phase HPLC technique. Clin Chim Acta 405:60–65CrossRef DePalo EF, Antonelli G, Benetazzo A, Prearo M, Gatti R (2009) Human saliva cortisone and cortisol simultaneous analysis using reverse phase HPLC technique. Clin Chim Acta 405:60–65CrossRef
30.
go back to reference Raff H, Sluss PM (2008) Pre-analytical issues for testosterone and estradiol assays. Steroids 73:1297–1304PubMedCrossRef Raff H, Sluss PM (2008) Pre-analytical issues for testosterone and estradiol assays. Steroids 73:1297–1304PubMedCrossRef
31.
go back to reference Broderick JE, Arnold D, Kudielka BM, Kirschbaum C (2004) Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 29:636–650PubMedCrossRef Broderick JE, Arnold D, Kudielka BM, Kirschbaum C (2004) Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 29:636–650PubMedCrossRef
32.
go back to reference Perogamvros I, Keevil BG, Ray DW, Trainer PJ (2010) Salivary cortisone is a potential biomarker for serum free cortisol. J Clin Endocrinol Metab 95:4951–4958PubMedCrossRef Perogamvros I, Keevil BG, Ray DW, Trainer PJ (2010) Salivary cortisone is a potential biomarker for serum free cortisol. J Clin Endocrinol Metab 95:4951–4958PubMedCrossRef
33.
go back to reference Raff H (2008–2009) Cushing’s syndrome: diagnosis using late-night salivary cortisol measurement. Clin Lab Int (CLI) 12:6–8 (Dec 2008–Jan 2009) Raff H (2008–2009) Cushing’s syndrome: diagnosis using late-night salivary cortisol measurement. Clin Lab Int (CLI) 12:6–8 (Dec 2008–Jan 2009)
34.
go back to reference Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA (2004) Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 46:39–46PubMedCrossRef Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA (2004) Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 46:39–46PubMedCrossRef
35.
go back to reference Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A (2009) Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 94:456–462PubMedCrossRef Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A (2009) Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 94:456–462PubMedCrossRef
36.
go back to reference Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN (2009) Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin Endocrinol (Oxf) 70:516–521CrossRef Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN (2009) Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin Endocrinol (Oxf) 70:516–521CrossRef
37.
go back to reference Mullan K, Black N, Thiraviaraj A, Bell PM, Burgess C, Hunter SJ, McCance DR, Leslie H, Sheridan B, Atkinson AB (2010) Is there value in routine screening for Cushing’s syndrome in patients with diabetes. J Clin Endocrinol Metab 95:2262–2265PubMedCrossRef Mullan K, Black N, Thiraviaraj A, Bell PM, Burgess C, Hunter SJ, McCance DR, Leslie H, Sheridan B, Atkinson AB (2010) Is there value in routine screening for Cushing’s syndrome in patients with diabetes. J Clin Endocrinol Metab 95:2262–2265PubMedCrossRef
38.
go back to reference Newsome S, Chen K, Hoang J, Wilson JD, Potter JM, Hickman PE (2008) Cushing’s syndrome in a clinic population with diabetes. Intern Med J 38:178–182PubMedCrossRef Newsome S, Chen K, Hoang J, Wilson JD, Potter JM, Hickman PE (2008) Cushing’s syndrome in a clinic population with diabetes. Intern Med J 38:178–182PubMedCrossRef
39.
go back to reference Baid SK, Rubino D, Sinaii N, Ramsey S, Frank A, Nieman LK (2009) Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J Clin Endocrinol Metab 94:3857–3864PubMedCrossRef Baid SK, Rubino D, Sinaii N, Ramsey S, Frank A, Nieman LK (2009) Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J Clin Endocrinol Metab 94:3857–3864PubMedCrossRef
40.
go back to reference Carroll T, Raff H, Findling JW (2009) Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 15:335–342PubMedCrossRef Carroll T, Raff H, Findling JW (2009) Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 15:335–342PubMedCrossRef
41.
go back to reference Kidambi S, Raff H, Findling JW (2007) Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur J Endocrinol 157:725–731PubMedCrossRef Kidambi S, Raff H, Findling JW (2007) Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur J Endocrinol 157:725–731PubMedCrossRef
42.
go back to reference Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A (2002) Bone density and biochemical bone markers in patients with adrenal incidentalomas: effect of subclinical hypercortisolism. Rev Méd Interne 23:508–517PubMedCrossRef Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A (2002) Bone density and biochemical bone markers in patients with adrenal incidentalomas: effect of subclinical hypercortisolism. Rev Méd Interne 23:508–517PubMedCrossRef
43.
go back to reference Chiodini I (2011) Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223–1236 Chiodini I (2011) Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223–1236
44.
go back to reference Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A (2009) Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab 94:3207–3214PubMedCrossRef Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A (2009) Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab 94:3207–3214PubMedCrossRef
45.
go back to reference Morelli V, Vainicher CE, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I (2011) Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res. doi:10.1002/jbmr.398 Morelli V, Vainicher CE, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I (2011) Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res. doi:10.​1002/​jbmr.​398
46.
go back to reference Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I (2009) The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol 160:87–92PubMedCrossRef Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I (2009) The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol 160:87–92PubMedCrossRef
47.
go back to reference Deutschbein T, Unger N, Hinrichs J, Walz MK, Mann K, Petersenn S (2009) Late-night and low-dose dexamethasone-suppressed cortisol and serum for the diagnosis of cortisol-secretion adrenal adenomas. Eur J Endocrinol 161:747–753PubMedCrossRef Deutschbein T, Unger N, Hinrichs J, Walz MK, Mann K, Petersenn S (2009) Late-night and low-dose dexamethasone-suppressed cortisol and serum for the diagnosis of cortisol-secretion adrenal adenomas. Eur J Endocrinol 161:747–753PubMedCrossRef
48.
go back to reference Sereg M, Toke J, Patocs A, Varga I, Igaz P, Szucs N, Horanyi J, Pusztai P, Czirjak S, Glaz E, Racz K, Toth M (2011) Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing’s syndrome. Steroids 76:38–42PubMedCrossRef Sereg M, Toke J, Patocs A, Varga I, Igaz P, Szucs N, Horanyi J, Pusztai P, Czirjak S, Glaz E, Racz K, Toth M (2011) Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing’s syndrome. Steroids 76:38–42PubMedCrossRef
49.
go back to reference Aghi MK, Petit J, Chapman P, Loeffler J, Klibanski A, Biller BM, Swearingen B (2008) Management of recurrent and refractory Cushing’s disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg 55:141–144PubMed Aghi MK, Petit J, Chapman P, Loeffler J, Klibanski A, Biller BM, Swearingen B (2008) Management of recurrent and refractory Cushing’s disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg 55:141–144PubMed
50.
go back to reference Carrasco CA, Coste J, Guignat L, Groussin L, Dugué MA, Gaillard S, Bertagna X, Bertherat J (2008) Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J Clin Endocrinol Metab 93:4728–4734PubMedCrossRef Carrasco CA, Coste J, Guignat L, Groussin L, Dugué MA, Gaillard S, Bertagna X, Bertherat J (2008) Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J Clin Endocrinol Metab 93:4728–4734PubMedCrossRef
Metadata
Title
Cushing’s syndrome: diagnosis and surveillance using salivary cortisol
Author
Hershel Raff
Publication date
01-03-2012
Publisher
Springer US
Published in
Pituitary / Issue 1/2012
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0333-0

Other articles of this Issue 1/2012

Pituitary 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.